Correction: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Rui Guo(Sun Yat-sen University), Nan Li(Academy of Medical Sciences), Zhi Yang(Peking University), Xiangxi Meng(Biotechnology Research Institute), Wei Zhao(Ningxia University), Wanpu Yan(Peking University), Qing Xie(Nanchang University), Fei Wang(Zhejiang Chinese Medical University), Huabo Su(Augusta University)
Cited by 1
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior
|Cell|2019|323
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|The Lancet|2021|234
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165